Saks Samuel R
SEC-identified person · CIK 1365615 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Protagonist Therapeutics, Inc PTGX | Chief Medical Officer | filed 2018 - 2021 |
| Protein Design Labs INC/DE pdli | Director | filed 2015 - 2019 |
| Tonix Pharmaceuticals Holding Corp. TNXP | Director | filed 2013 - 2018 |
| Depomed INC DEPO | Director | filed 2012 - 2016 |
| Auspex Pharmaceuticals, Inc. ASPX | Director · Chief Development Officer | filed 2014 - 2015 |
| Trubion Pharmaceuticals, Inc TRBN | Director | filed 2006 - 2010 |
| Srkp 4 INC CGRB | Director | filed 2007 - 2009 |
| Jazz Pharmaceuticals plc JAZZ | Director · Chief Executive Officer | filed 2007 - 2009 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.